Werewolf Therapeutics, Inc.
HOWL
$0.39
$0.001.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -62.47% | -63.48% | -58.59% | -6.68% | -14.71% |
| Gross Profit | 232.28% | 63.48% | 58.59% | 6.68% | 7.41% |
| SG&A Expenses | 51.15% | -21.26% | -40.28% | -11.31% | -7.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.95% | -50.16% | -53.72% | -8.16% | -12.74% |
| Operating Income | 148.67% | 50.16% | 53.72% | 8.16% | 7.48% |
| Income Before Tax | 120.41% | 25.19% | 58.92% | 1.82% | -4.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 120.41% | 25.19% | 58.92% | 1.82% | -4.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 120.41% | 25.19% | 58.92% | 1.82% | -4.25% |
| EBIT | 148.67% | 50.16% | 53.72% | 8.16% | 7.48% |
| EBITDA | 164.13% | 51.22% | 54.70% | 8.07% | 7.40% |
| EPS Basic | 118.88% | 30.98% | 62.26% | 6.32% | -0.88% |
| Normalized Basic EPS | 143.26% | 52.93% | 62.26% | 6.29% | -4.21% |
| EPS Diluted | 118.88% | 30.61% | 57.14% | 5.64% | 6.02% |
| Normalized Diluted EPS | 143.26% | 52.93% | 62.89% | 6.29% | -5.49% |
| Average Basic Shares Outstanding | 8.04% | 8.41% | 8.87% | 4.80% | 3.36% |
| Average Diluted Shares Outstanding | 8.04% | 8.41% | 10.65% | 4.80% | 2.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |